Dingyi Lv
Impact in
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
-
- interferon and immune responses
Papers in
-
- Inflammasome and immune disorders 7
-
- Lipid metabolism and disorders 4
- Viral Infections and Immunology Research 2
- Co-authors
- Minghao Luo (21 shared papers)Suxin Luo (16 shared papers)Jianghong Yan (10 shared papers)Longxiang Huang (9 shared papers)Yongzheng Guo (8 shared papers)Zhe Cheng (7 shared papers)Ruiyu Wang (6 shared papers)Ke Liao (2 shared papers)
- Journals
- Heliyon (4 papers)International Immunopharmacology (3 papers)Microvascular Research (2 papers)Biochemical and Biophysical Research Communications (2 papers)Oxidative Medicine and Cellular Longevity (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Dingyi Lv
29 papers receiving 504 citations
Peers
Comparison fields: 5 of 79
- Geriatrics and Gerontology 32
- Immunology 105
- Physiology 17
- Rehabilitation 22
- Nephrology 23
Countries citing papers authored by Dingyi Lv
This map shows the geographic impact of Dingyi Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dingyi Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dingyi Lv more than expected).
Fields of papers citing papers by Dingyi Lv
This network shows the impact of papers produced by Dingyi Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dingyi Lv. The network helps show where Dingyi Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Dingyi Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 54 | |
| 2 | 2023 | 35 | |
| 3 | 2021 | 32 | |
| 4 | 2020 | 30 | |
| 5 | 2022 | 29 | |
| 6 | 2021 | 25 | |
| 7 | 2020 | 25 | |
| 8 | 2022 | 23 | |
| 9 | 2023 | 22 | |
| 10 | 2021 | 22 | |
| 11 | 2021 | 22 | |
| 12 | 2020 | 21 | |
| 13 | 2021 | 18 | |
| 14 | 2020 | 18 | |
| 15 | 2020 | 17 | |
| 16 | 2021 | 15 | |
| 17 | 2022 | 14 | |
| 18 | 2022 | 13 | |
| 19 | 2022 | 13 | |
| 20 | 2022 | 12 |
About Dingyi Lv
Dingyi Lv is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Immunology, Physiology and Complementary and alternative medicine, having authored 29 papers that have together received 507 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (7 papers), Lipid metabolism and disorders (4 papers), Nitric Oxide and Endothelin Effects (3 papers), interferon and immune responses (3 papers), Traditional Chinese Medicine Analysis (3 papers), Phytochemistry and Biological Activities (2 papers), Intracerebral and Subarachnoid Hemorrhage Research (2 papers) and Viral Infections and Immunology Research (2 papers). The work is most often cited by research in Geriatrics and Gerontology (32 citations), Immunology (105 citations), Physiology (17 citations), Rehabilitation (22 citations) and Nephrology (23 citations). Dingyi Lv has collaborated with scholars based in China and United States. Frequent co-authors include Minghao Luo, Suxin Luo, Jianghong Yan, Longxiang Huang, Yongzheng Guo, Zhe Cheng, Ruiyu Wang, Ke Liao, Yu Hu and Jian Shen. Their work appears in journals such as Heliyon, International Immunopharmacology, Microvascular Research, Biochemical and Biophysical Research Communications and Oxidative Medicine and Cellular Longevity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.